Sign In
Buy R
$260.38
+2.32 (+0.90%)
At Close: Jun 03, 2026
Vera Quinn of Cydcor Named Entrepreneur Of the Year(R) 2026 Greater Los Angeles Finalist by EY US
01:00pm, Tuesday, 19'th May 2026
EY US celebrates ambitious entrepreneurs shaping the future of business Los Angeles, California--(Newsfile Corp. - May 19, 2026) - Vera Quinn, CEO of Cydcor, has been named a finalist for the Entrepre
GMG's THERMAL-XR(R) to be Applied Exclusively & Distributed to Global Oil and Gas/LNG Industry with Curran International
08:05am, Tuesday, 19'th May 2026
Brisbane, Queensland, Australia--(Newsfile Corp. - May 19, 2026) - Graphene Manufacturing Group Ltd (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce the signing of a global d
Spago Nanomedical Presents Tumorad(R) Clinical Data at the International ANZSNM 2026 Conference
02:40am, Monday, 18'th May 2026
LUND, SE / ACCESS Newswire / May 18, 2026 / Spago Nanomedical AB (publ)(STO:SPAGO.ST)(FRA:7UX.F) today announces that case findings from its ongoing Phase I/IIa clinical study Tumorad-01 have been pre
Are Investors Undervaluing Ryder System (R) Right Now?
10:41am, Thursday, 14'th May 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Caldwell Announces Relaunch of Canada's Top 40 Under 40(R) Award Program
09:00am, Wednesday, 13'th May 2026
TORONTO, ON / ACCESS Newswire / May 13, 2026 / Retained executive search firm Caldwell (TSX:CWL)(OTCQX:CWLPF) today announced the relaunch of Canada's Top 40 Under 40® Award Program, renewing its com
Tenon(R) Medical Reports First Quarter 2026 Financial Results
04:05pm, Tuesday, 12'th May 2026
~ First Quarter 2026 Revenue of $1.4 Million, an Increase of Approximately 90% Compared to Prior Year ~ ~ First Quarter Gross Profit of $0.9 Million, an Increase of Approximately 193% Compared to Prio
Ryder System, Inc. (R) Presents at Bank of America 33rd Annual Industrials, Transportation and Airlines Key Leaders Conference Transcript
40% objective response rate ( ORR) as single agent in heavily pre - treated patients with advanced Cutaneous T-Cell Lymphoma (CTCL) Durable responses observed, including a complete response lasting
LUND, SE / ACCESS Newswire / May 12, 2026 / BioInvent International (STO:BINV) - BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a leader in the discovery of novel immune-modulatory
Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology
08:00am, Tuesday, 12'th May 2026
~ Patent Extends Jurisdiction and Protection Through 2042 ~ SAN DIEGO, CA / ACCESS Newswire / May 12, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage phar
Quarterly Report Q1 2026: Orviglance(R) Approaching Transformative Milestones
01:50am, Tuesday, 12'th May 2026
MALMÖ, SE / ACCESS Newswire / May 12, 2026 / Ascelia Pharma AB (publ) (STO:ACE) today published its Interim Report Q1 for 2026 (January - March), which is now available on the company's website: Fina
Theralase(R) Announces $4 Million Brokered LIFE Offering
07:10pm, Tuesday, 05'th May 2026
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - Theralase® Technologies Inc. (TSXV: TL
Ryder CEO to Address Bank of America Securities Industrials, Transportation, and Airlines Key Leaders Conference
06:55am, Tuesday, 05'th May 2026
MIAMI--(BUSINESS WIRE)-- #RyderEverbetter--Ryder System, Inc. (NYSE: R) Chief Executive Officer John Diez will present a company update at the 2026 Bank of America Securities Industrials, Transportati
Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update
05:22pm, Monday, 04'th May 2026
Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the
Gelum Shares Approved for Trading on the OTCQB(R) Venture Market
08:00am, Monday, 04'th May 2026
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - Gelum Resources Ltd. (CSE: GMR) (OTCQB: GMRCF) ("Gelum" or the "Company") reports that the Company's common shares have been re-approved
